local_hospital

Szpital Bielanski Im.Ks.Jerzego Popieluszki samodzielny publiczny zakład opieki zdrowotnej

Address
lock Available on a paid plan

Endocrinology and Hormonal Disorders

At Szpital Bielanski Im.Ks.Jerzego Popieluszki samodzielny publiczny zakład opieki zdrowotnej, clinical research in hormonal diseases focuses on Classic Congenital Adrenal Hyperplasia and related adrenal conditions. These studies are designed to assess new treatment options that may help improve hormonal control while reducing the burden of long-term steroid use.

  • Evaluating a new therapy for better adrenal hormone regulation
  • Studying ways to lower glucocorticoid use while maintaining disease control
  • Assessing safety and tolerability in patients with adrenal disorders

The work reflects a strong interest in improving day-to-day management for people living with complex endocrine conditions.

Cardiovascular and Vascular Medicine

Clinical trials in cardiovascular diseases at this Warsaw site address acute coronary syndrome and lower extremity artery disease. The research is aimed at improving treatment effectiveness and safety, with a focus on reducing complications after vascular and cardiac care.

  • Testing treatment approaches to lower the risk of restenosis in leg arteries
  • Comparing antiplatelet strategies for safer heart care after acute coronary events
  • Exploring ways to improve outcomes in patients with peripheral artery disease

These studies support better recovery and longer-term protection for patients with serious circulatory disorders.

Metabolic and Wound Healing Research

Research in nutritional and metabolic diseases includes studies on diabetic foot ulcer and chronic wound care. The trials are focused on testing advanced treatment approaches that may support healing and reduce the impact of difficult-to-treat diabetic complications.

  • Assessing a new cell-based treatment for chronic diabetic wounds
  • Evaluating wound healing effectiveness compared with standard care
  • Studying early safety and tolerance of regenerative therapies

This area highlights the site’s interest in improving outcomes for patients with long-lasting diabetes-related tissue damage.

Infectious Disease Prevention and Immunization

The site also contributes to bacterial infections and mycoses research through vaccine studies and prevention-focused trials. Work in this area includes pneumococcal immunization, meningococcal infection prevention, and protection against RSV in young children.

  • Testing vaccines for stronger immune responses in infants and toddlers
  • Evaluating protection against serious respiratory and bacterial infections
  • Supporting prevention strategies for early childhood infectious disease

These studies are centered on improving public health through better immunization and infection prevention.

Psychiatry, Psychology, and Behavioral Health

Clinical research in psychiatry and psychology covers mental disorders, psychological phenomena, and behavior and behavior mechanisms. One major focus is Compulsive Sexual Behaviour Disorder, where trials are exploring whether different treatments can reduce symptom severity and improve quality of life.

  • Comparing medicines and combination approaches for symptom reduction
  • Studying treatment effectiveness for behavioral control
  • Assessing options that may support mental health and daily functioning

These projects show an interest in helping patients manage complex behavioral and psychological conditions through evidence-based care.

Site Overview

assignment
8
connected trials
corporate_fare
8
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
8
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 6 therapeutic areas and 11 of 12 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
8
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
8
Outperforms 75% of sites
public
Therapeutic diversity
8areas
Outperforms 92% of sites
groups
Sponsor diversity
8sponsors
Outperforms 78% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Szpital Bielanski Im.Ks.Jerzego Popieluszki samodzielny publiczny zakład opieki zdrowotnej

lock Showing 1 of 8 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term InfantsMerck Sharp & Dohme LLCPhase IVNot RecruitingNov 2022Feb 2024

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Escitalopram Oxalate2Unknown2025-06-122025-06-12

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.